Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights).

NACompletedINTERVENTIONAL
Enrollment

504

Participants

Timeline

Start Date

September 30, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Myopia
Interventions
DEVICE

etafilcon A

DEVICE

galyfilcon A

Trial Locations (25)

15108

West Hills Vision Center, Moon Township

30260

Clayton Eye Center, Morrow

32256

Dr. Ted Brink and Associates, Jacksonville

32803

Jack J. Yager, OD, Orlando

37027

Kenneth A. Young, OD, Brentwood

37205

Gary W. Jerkins, MD, Nashville

43202

Central Ohio Eyecare, Columbus

45701

Drs. Quinn, Quinn and Associates, Athens

48823

Lee Rigel, East Lansing

53562

Scott Jens, OD, Middleton

61701

Eyecare Associates, Bloomington

63121

Univ Missouri at St. Louis, College of Optometry, St Louis

64093

InSight Eyecare, Warrensburg

66030

Drs. Hawks, Besler & Rogers, Gardner

75006

Charles Wegman, OD, Carrollton

75023

First Eye Care Plano, Plano

77450

Wishnow-Sugar Vision Group, Katy

79119

Premier Vision, Amarillo

80027

Fukai and Associates, Louisville

82070

Snowy Range Vision Center, Laramie

84106

Dr. William Bogus, Salt Lake City

92626

Steven S. Grant, OD, Costa Mesa

93704

Cole, Cole, and Krohn, Fresno

97526

Kenji Hamada, OD, Grants Pass

06002

Peter C. Donshik, MD, Bloomfield

All Listed Sponsors
lead

Johnson & Johnson Vision Care, Inc.

INDUSTRY

NCT00241280 - Study Intended to Evaluate the Safety and Effectiveness of a Johnson & Johnson Vision Care Inc, (JJVCI) Contact Lens for Use on an Extended-wear Basis for up to 7 Days (6 Nights). | Biotech Hunter | Biotech Hunter